Positron emission tomography with fluorine-18 fluorodeoxyglucose to evaluate response of early breast carcinoma treated with stereotaxic interstitiallaser therapy

Citation
N. Nair et al., Positron emission tomography with fluorine-18 fluorodeoxyglucose to evaluate response of early breast carcinoma treated with stereotaxic interstitiallaser therapy, CLIN NUCL M, 25(7), 2000, pp. 505-507
Citations number
21
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
CLINICAL NUCLEAR MEDICINE
ISSN journal
03639762 → ACNP
Volume
25
Issue
7
Year of publication
2000
Pages
505 - 507
Database
ISI
SICI code
0363-9762(200007)25:7<505:PETWFF>2.0.ZU;2-H
Abstract
Stereotaxic interstitial laser therapy is a promising new alternative to su rgery to treat early-stage breast cancer. With this, laser energy coagulate s the tumor with controlled heat, leading to fibrosis. Fluorodeoxyglucose p ositron emission tomography (FDG PET) scanning was performed in four patien ts treated by this technique to determine the degree of necrosis after inte rstitial laser therapy. The results showed that FDG PET scanning was in clo se agreement with histopathologic findings, confirming complete necrosis in one patient and variable response in the other three patients. Uptake of F DG appears to be a reliable means to monitor treatment response after inter stitial laser therapy and may be useful in the management of breast cancer when used with this new procedure.